Can Ultrasonographic Findings Predict Response To Tumor Necrosis Factor-α Inhibitor Treatment In Rheumatoid Arthritis?

被引：0
|
作者：
Inanc, Nevsun [1 ]
Ozen, Gulsen [1 ]
Direskeneli, Haner [1 ]
机构：
[1] Marmara Univ, Sch Med, Istanbul, Turkey
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2803
引用
收藏
页码：S1200 / S1200
页数：1
相关论文
共 50 条
  • [21] Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
    Shin, Sungsik
    Chung, Kee Yang
    Kim, Dae Suk
    [J]. ANNALS OF DERMATOLOGY, 2016, 28 (03) : 402 - 403
  • [22] Efficacy of a Second Tumor Necrosis Factor Inhibitor (TNFi) in the Treatment of Rheumatoid Arthritis (RA)
    Reams, Jennifer
    Berger, Andrea
    Dunn, Philip
    O'Connell, Eva
    Torelli, William
    Bankert, Jason
    Bashir, Muhammed
    Denio, Alfred
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Increased tumor necrosis factor-α mRNA expression in whole blood from patients with rheumatoid arthritis:: Reduction after infliximab treatment does not predict response
    Pachot, Alexandre
    Arnaud, Beatrice
    Marrote, Hubert
    Cazalis, Marie-Angelique
    Diasparra, Jennifer
    Gouraud, Aurore
    Mougin, Bruno
    Miossec, Pierre
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (11) : 2158 - 2161
  • [24] Interleukin 10 and Tumor Necrosis Factor-α Genotypes in Rheumatoid Arthritis - Association with Clinical Response to Glucocorticoids
    de Paz, Banesa
    Alperi-Lopez, Mercedes
    Ballina-Garcia, Francisco J.
    Prado, Catuxa
    Mozo, Lourdes
    Gutierrez, Carmen
    Suarez, Ana
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 503 - 511
  • [25] JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-α
    Wang, Jianhua
    Li, Chuanyu
    Liu, Yuelong
    Mei, Wan
    Yu, Shaohua
    Liu, Cunren
    Zhang, Liming
    Cao, Xu
    Kimberly, Robert P.
    Grizzle, William
    Zhang, Huang-Ge
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (03): : 889 - 902
  • [26] Novel pathways that regulate tumor necrosis factor-α production in rheumatoid arthritis
    Gracie, JA
    Leung, BP
    McInnes, IB
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (03) : 270 - 275
  • [27] Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis
    Al-Aly, Ziyad
    Pan, Hui
    Zeringue, Angelique
    Xian, Hong
    Mcdonald, Jay R.
    El-Achkar, Tarek M.
    Eisen, Seth
    [J]. TRANSLATIONAL RESEARCH, 2011, 157 (01) : 10 - 18
  • [28] Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis
    L. V. Kozlovskaya
    N. A. Mukhin
    V. V. Rameev
    I. A. Sarkisova
    O. I. Epstein
    [J]. Bulletin of Experimental Biology and Medicine, 2003, 135 (Suppl 7) : 152 - 154
  • [29] Current tumor necrosis factor-α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis
    Liang, GC
    Cordero, M
    Dyer, A
    Chang, RW
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (09) : 1662 - 1665
  • [30] Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Francis Cook, E.
    Carney, Greg
    Schneeweiss, Sebastian
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S19 - S19
12345